Weight Reduce Injection UK: BMI Eligibility, How They Work and What to Expect

Could a prescription weight loss injection be suitable for you? The answer is not based on BMI alone.

Weight loss injections are prescription medicines that can help eligible adults manage overweight or obesity by affecting appetite and other biological pathways involved in hunger and food intake. They are not general slimming products and should only be used when a healthcare professional considers them appropriate.

The main injectable medicines included in current NICE adult weight management guidance are:

tirzepatide

semaglutide

and

liraglutide.

They are used alongside dietary changes and increased physical activity rather than as standalone treatments.

One of the most common questions is:

“What BMI do I need for weight loss injections?”

There are actually two different answers.

The first concerns the medicine's authorised UK indication.

The MHRA states that GLP 1 medicines authorised for weight management can be used for adults with a BMI of at least 30 kg/m², or at least 27 kg/m² when a relevant weight related health condition is also present. Tirzepatide's UK weight management authorisation follows this broad structure.

The second answer concerns NICE criteria for use within NHS weight management pathways.

These criteria can be narrower. For example, NICE recommends tirzepatide for adults with an initial BMI of at least 35 kg/m² and at least one weight related comorbidity, with lower BMI thresholds usually used for certain ethnic backgrounds.

That means someone may fall within a medicine's authorised indication but not automatically qualify for the same treatment through an NHS pathway.

Key things to know

Weight management injections currently work through either:

GLP 1 signalling

or

combined GIP and GLP 1 signalling.

Semaglutide and liraglutide are GLP 1 receptor agonists.

Tirzepatide acts on both GIP and GLP 1 pathways.

These medicines can help people feel fuller and may reduce hunger and food intake. They still form only one part of a wider weight management plan.

Treatment may also involve:

appropriate nutrition

physical activity

dose increases where needed

and

regular clinical follow up.

What Is a Weight Loss Injection?

A weight loss injection is a prescription medicine given under the skin to support weight management when it is medically appropriate.

BMI is one of the measures a healthcare professional may use when assessing whether someone is living with overweight or obesity. It is useful, but it does not tell the whole story. NICE also recommends considering waist to height ratio in adults with a BMI below 35 kg/m² when assessing health risks linked to excess weight.

Current NICE weight management guidance includes injectable:

tirzepatide

semaglutide

and

liraglutide

among the medicine options for adults.

They are not identical medicines. They differ in:

• active ingredient
• how they work
• injection frequency
• dose schedule
• eligibility criteria
• treatment duration
• safety considerations.

The exact medicine prescribed therefore matters. The right weight loss medication depends on your health, medical history and whether the treatment is suitable for you. There is no single injection that is right for everyone.

How Do Weight Loss Injections Work?

You may have heard people describe these medicines as “weight loss injections”, but they do not simply make body fat disappear.

GLP 1 is a natural hormone involved in appetite and blood glucose regulation. Medicines that act on the GLP 1 pathway can help people feel fuller and may reduce hunger and food intake.

Semaglutide and liraglutide work by activating GLP 1 receptors.

Tirzepatide acts on both GIP and GLP 1 receptors. GIP is another hormone pathway involved in appetite and blood sugar regulation.

For some people, these effects can make it easier to eat less over time. Weight reduction happens when overall energy intake is lower than the amount of energy the body uses.

This is why food choices and physical activity still matter during treatment.

Do Weight Loss Injections Burn Fat Directly?

Not in the way the phrase “fat burning injection” might suggest.

These medicines do not simply dissolve stored body fat. Instead, they affect appetite and food intake, which can contribute to weight loss over time.

A simple way to think about it is:

medicine affects appetite signals

↓

hunger and food intake may decrease

↓

overall energy intake may fall

↓

body weight may reduce over time.

The amount of weight change can vary from person to person, which is why treatment should be monitored rather than viewed as a guaranteed result.

Which Weight Loss Injections Are Used in the UK?

Current NICE weight management guidance includes three injectable options.

NICE lists these alongside the oral medicine orlistat within its adult weight management framework. The medicines have different eligibility criteria and treatment settings, so injection frequency alone does not tell you which one may be suitable.

What Is Tirzepatide?

Tirzepatide is a weekly injectable medicine used for weight management in eligible adults.

It acts on:

GIP

and

GLP 1

receptors.

The MHRA authorised tirzepatide for adult weight management in November 2023 for adults with:

BMI of 30 kg/m² or above

or

BMI between 27 and 30 kg/m² with at least one relevant weight related health problem.

It is intended to be used alongside a reduced calorie diet and increased physical activity.

Whether tirzepatide is suitable for you depends on your individual circumstances and the prescribing pathway being used.

What Is Semaglutide?

Semaglutide is a GLP 1 receptor agonist.

The semaglutide product used specifically for weight management is Wegovy. It is available as an injection and is normally given once a week.

NICE recommends semaglutide for selected adults alongside a reduced calorie diet and increased physical activity, subject to its specific eligibility criteria and specialist weight management service requirements.

A new single dose 7.2 mg Wegovy pen was approved by the MHRA in April 2026 for adults with obesity. This is a higher dose presentation of semaglutide rather than a completely new active medicine.

What Is Liraglutide?

Liraglutide is another GLP 1 receptor agonist used for weight management in appropriate adults.

Unlike semaglutide and tirzepatide, which are generally given weekly for weight management, liraglutide is injected daily.

NICE includes liraglutide among adult weight management medicine options. Its NHS criteria are specific and include a BMI of at least 35 kg/m², non diabetic hyperglycaemia and a high risk of cardiovascular disease, with lower BMI thresholds usually used for certain ethnic backgrounds.

What BMI Do You Need for Weight Loss Injections?

This depends on whether you are asking about the medicine's authorised indication or an NHS treatment pathway.

For the broad UK authorised indications of weight management GLP 1 medicines, the MHRA describes treatment for people who have:

BMI of at least 30 kg/m²

or

BMI of at least 27 kg/m² plus a relevant weight related health condition.

Examples of relevant weight related health conditions can include:

• high blood pressure
• abnormal blood fats
• obstructive sleep apnoea
• prediabetes
• type 2 diabetes
• cardiovascular disease.

The exact eligibility requirements depend on the medicine and its authorised indication.

Is BMI 27 Enough for a Weight Loss Injection?

Not necessarily.

A BMI of 27 to below 30 kg/m² may fall within the authorised weight management indication for some medicines when a relevant weight related health condition is also present. A BMI in this range does not automatically mean that you will be prescribed an injection.

The prescriber will also consider the specific medicine, your health, current medicines and whether the treatment is appropriate for you.

NICE criteria for NHS treatment can be more restrictive than the medicine's wider authorised indication.

Is BMI 30 Enough?

A BMI of 30 kg/m² or above falls within the broad obesity threshold used in UK weight management authorisations for relevant medicines.

However, this does not mean that a prescription is automatic.

A prescriber may need to consider:

• medical history
• current medicines
• possible contraindications
• previous weight management treatment
• potential treatment risks
• your individual circumstances.

NHS access may also have additional NICE and local commissioning requirements.

What BMI Does NICE Require for Tirzepatide?

NICE recommends tirzepatide for weight management in adults with:

an initial BMI of at least 35 kg/m²

and

at least one weight related comorbidity.

For people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African Caribbean ethnic backgrounds, NICE recommends using lower BMI thresholds, usually reduced by 2.5 kg/m².

This is because people from these groups can have a higher risk of central adiposity and related health problems at lower BMI levels.

What BMI Does NICE Require for Semaglutide?

NICE recommends semaglutide for adults who have at least one weight related comorbidity and either:

a BMI of at least 35 kg/m²

or

a BMI from 30 to 34.9 kg/m² and who meet the criteria for referral to specialist overweight and obesity management services.

Lower BMI thresholds are usually used for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African Caribbean ethnic backgrounds.

These are NICE treatment criteria and should not be confused with the broader authorised indication for the medicine.

Why Are Private and NHS BMI Rules Different?

It can be confusing when you see different BMI numbers online, but there is a reason for this.

Two different decisions are involved.

MHRA Authorisation

This sets out the medical conditions and patient groups for which a medicine has been authorised in the UK.

NICE Recommendation

NICE guidance sets out how medicines should be used within NHS care, including specific clinical and service criteria.

So, a medicine being authorised for a particular group does not automatically mean that everyone in that group will receive it through the NHS.

Your local NHS pathway can also affect how treatment is accessed.

How Do I Get a Weight Loss Injection?

If you are considering a weight loss injection, the first step is a proper health assessment rather than simply choosing a product.

There are broadly two regulated routes:

an NHS treatment pathway

or

private prescribing.

In either case, an appropriately qualified healthcare professional should assess whether treatment is suitable.

The assessment may include:

• height
• weight
• BMI
• weight related health conditions
• medical history
• current medicines
• previous weight management treatment
• relevant contraindications.

GLP 1 medicines are prescription only medicines in the UK. For private treatment, the MHRA says a consultation with a healthcare professional must take place before a prescription is issued.

Can You Get Weight Loss Injections Online?

Yes, weight loss injections can be prescribed privately through a legitimate online healthcare service, but there should still be a proper medical assessment.

Online does not mean unrestricted.

A prescriber should review the information needed to decide whether the medicine is suitable before issuing a prescription. The MHRA specifically advises people not to buy GLP 1 medicines from unregulated sellers, beauty salons, social media or anywhere that supplies them without a prior consultation.

Be particularly cautious if a website offers a prescription injection without asking about your health, medicines, BMI or other relevant information.

How Can You Tell if a Weight Loss Injection Is Genuine?

The safest approach is to use a legitimate prescribing and pharmacy service rather than buying an injection from an unknown seller.

The MHRA warns against buying GLP 1 medicines from unregulated websites, social media sellers and beauty businesses. It has also reported fake GLP 1 medicines, which can expose people to serious health risks.

Before ordering, check that the service involves a proper healthcare consultation and that the medicine is supplied through an authorised pharmacy route.

If something is being sold without a prescription or without any meaningful health assessment, it is worth stopping and checking the source before using it.

Are Weight Loss Injection Vials Safe to Buy Online?

Be very cautious with products sold as powders or vials that need to be mixed before they are injected.

The MHRA states that legitimate GLP 1 medicines are supplied in pre filled injection pens or, for some medicines, in tablet form. Products supplied as powder in vials that need to be mixed with liquid before injection are not authorised GLP 1 medicines and can pose significant health risks.

This is particularly important when products are promoted online as “research peptides” or as alternatives to licensed weight management medicines.

If you are unsure about a product, speak to a pharmacist or prescriber before using it.

What Is the Newest Weight Loss Injection Called?

This question can mean two different things: a newer active medicine or a newer version of an existing medicine.

Newest Major Injectable Active Medicine

Among the three injectable medicines included in the current NICE adult weight management framework, tirzepatide is the newer active medicine compared with semaglutide and liraglutide.

The MHRA authorised tirzepatide for weight management in the UK in November 2023.

Newest Major Injection Presentation

On 14 April 2026, the MHRA approved a new single dose 7.2 mg Wegovy pen for adults with obesity.

This is a new semaglutide injection presentation rather than a completely new active medicine. The 7.2 mg dose is administered as one injection.

So, when you see a “new” weight loss injection mentioned online, it is worth checking whether it is a new medicine, a new dose or simply a new way of delivering an existing medicine.

Is Retatrutide the Newest Weight Loss Injection?

Retatrutide has attracted a lot of attention online, but it should not currently be described as an authorised UK weight management medicine.

The MHRA warned in July 2026 that retatrutide had not been authorised for use in the UK and that products being sold as retatrutide were being supplied illegally. Retatrutide also appears in MHRA records as an investigational active substance for obesity rather than an authorised marketed medicine.

This means you should not buy or use products advertised online as retatrutide injections. If you come across one, speak to a healthcare professional rather than assuming that an online product is safe because it is described as a weight loss medicine.

Is the 7.2 mg Wegovy Pen a New Medicine?

No.

The 7.2 mg Wegovy pen contains semaglutide, which is already authorised for weight management.

What changed in April 2026 was the presentation. The MHRA approved a new single dose 7.2 mg Wegovy pen for adults with obesity. The 7.2 mg dose is given as one injection.

So, this was a new pen and dose presentation rather than a completely new active ingredient.

How Quickly Does a Weight Loss Injection Work?

It is understandable to want to know when you will start seeing a difference. However, weight loss treatment is generally assessed over months rather than days.

Some people may notice changes in appetite or hunger before they see a noticeable change on the scales. Others may notice very little at first.

Weight does not usually decrease at exactly the same rate every week. Treatment may also start at a lower dose and increase gradually to help manage side effects.

For tirzepatide, NICE recommends reviewing whether treatment should continue if less than 5% of the initial body weight has been lost after 6 months on the highest tolerated dose. For semaglutide, NICE recommends considering stopping if less than 5% of the initial weight has been lost after 6 months of treatment.

These review points show why a first week or two does not tell you how well treatment may work for you.

Will You Lose Weight in the First Week?

Some people may notice changes in:

appetite

hunger

or

portion sizes

during the early stages of treatment.

Others may notice very little at first.

One week's change on the scales is not a reliable way to judge how well a weight loss medicine is working. Your weight can naturally move up and down because of things such as:

• hydration
• food and drink intake
• digestive contents.

If you do not see the change you expected in the first week, do not take extra medicine or change your dose yourself. Follow the dose schedule given by your prescriber.

Can You Increase the Dose to Lose Weight Faster?

No. You should follow the dose escalation schedule prescribed for your medicine.

The MHRA has specifically warned people not to increase GLP 1 medicine doses in an attempt to speed up weight loss. Taking more than prescribed can increase the risk of side effects.

A higher dose is not automatically a better or faster option. Dose changes should be made by the prescriber and follow the authorised dosing schedule for the specific medicine.

How Quickly Is the Dose Increased?

The schedule depends on the medicine you are using.

For example, standard Wegovy treatment starts at:

0.25 mg once a week

The dose is then increased at four week intervals according to the authorised dosing schedule and the prescriber's instructions.

Tirzepatide has a different dose schedule, so you should never copy the escalation plan for one medicine onto another.

If you are unsure when your next dose increase is due, check with your prescriber or pharmacist.

How Much Weight Should You Expect to Lose?

There is no single amount of weight that everyone should expect to lose.

Your response can depend on:

• the medicine
• the dose
• how long you use it
• your starting weight
• your food intake
• your activity levels
• how your body responds
• how consistently the treatment is used.

Your prescriber can help you understand what would be a realistic goal for your treatment. Be cautious of websites or sellers that promise a specific amount of weight loss.

What Does “Weight Loss Injection Face” Mean?

You may have seen the phrase “weight loss injection face” online. It is an informal term, not a medical diagnosis used in NICE or MHRA weight management guidance.

People generally use it to describe a face that looks:

slimmer

less full

or

more defined

after significant weight loss.

When overall body weight decreases, changes can occur in different areas of the body, including the face. This does not mean that the injection is specifically damaging facial tissue.

If you notice noticeable changes in your appearance during weight loss, the more useful questions are whether your weight is changing too quickly, whether you are getting enough nutrition and whether your treatment is still appropriate.

Does Every Person Using an Injection Get Facial Changes?

No.

People store body fat differently, so changes in the face can vary from person to person.

Visible changes may depend on factors such as:

• the amount of weight lost
• starting body composition
• age
• skin characteristics
• genetics.

Facial changes should therefore not be treated as an inevitable side effect of weight loss injections.

Can You Prevent Facial Slimming?

You cannot choose exactly where your body loses stored fat.

Rather than trying to prevent normal changes in one particular area, focus on losing weight in a way that supports your overall health.

The MHRA advises people using GLP 1 medicines to maintain good nutrition and physical activity and not to increase their dose in an attempt to speed up weight loss.

If you are losing weight very quickly or struggling to eat and drink enough, speak to your prescriber.

Can Weight Loss Injections Cause Kidney Stones?

Kidney stones should not be described as a typical or established side effect of GLP 1 medicines.

There is, however, an important kidney related concern. GLP 1 medicines can cause gastrointestinal side effects such as:

nausea

vomiting

and

diarrhoea.

If these become severe, they can lead to dehydration. The MHRA warns that severe dehydration can sometimes result in serious complications, including kidney problems that may require hospital treatment.

So, while kidney stones are not a routine GLP 1 side effect, severe vomiting or diarrhoea should not be ignored.

Are Kidney Stones and Gallstones the Same Thing?

No. They are two different conditions.

Kidney stones form in the urinary system, while gallstones form in the gallbladder.

The MHRA recognises gallbladder disorders, including gallstone disease, as possible less common serious adverse effects associated with GLP 1 medicines.

This distinction matters because seeing the word “stones” in information about these medicines does not mean that the warning is about kidney stones.

Can Dehydration Affect the Kidneys?

Yes.

Repeated vomiting or diarrhoea can cause the body to lose a significant amount of fluid. Severe dehydration can affect kidney function and, in some cases, may require hospital treatment.

If you cannot keep fluids down, have persistent vomiting or diarrhoea, or become significantly unwell, contact a healthcare professional promptly.

What Are the Common Side Effects of Weight Loss Injections?

Gastrointestinal side effects are among the most common problems reported with GLP 1 medicines.

These can include:

• nausea
• vomiting
• diarrhoea
• constipation.

They can be more noticeable when treatment starts or after a dose increase.

This is one reason these medicines are generally started at a lower dose and increased gradually according to the specific medicine's dosing schedule.

If side effects are difficult to manage, speak to your prescriber rather than stopping, restarting or changing the dose yourself.

What Serious Side Effects Should You Know About?

Most side effects are not serious, but there are some symptoms that need prompt medical attention.

One important risk is acute pancreatitis, which is inflammation of the pancreas. The MHRA strengthened warnings about this risk for GLP 1 receptor agonists and dual GLP 1/GIP medicines in January 2026.

Seek urgent medical attention if you develop:

severe and persistent abdominal pain

particularly if the pain:

radiates towards the back

and may be accompanied by:

nausea or vomiting.

Do not simply assume that severe or persistent abdominal pain is a normal side effect of the injection.

Can Semaglutide Affect Vision?

There is a very rare eye related risk associated with semaglutide called non arteritic anterior ischaemic optic neuropathy, or NAION.

The MHRA updated semaglutide safety information in February 2026 after reviewing evidence about this risk. NAION can cause sudden, usually painless loss of vision, often in one eye.

If you experience sudden loss of vision or a rapid worsening of your eyesight while taking semaglutide, seek urgent medical attention.

This warning relates specifically to semaglutide and should not be applied to every weight management medicine in the same way.

Do Weight Loss Injections Affect the Gallbladder?

They can be associated with gallbladder problems.

The MHRA includes gallbladder disorders and gallstone disease among the less common serious adverse effects associated with GLP 1 medicines.

If you develop persistent or significant abdominal pain while using a weight loss injection, do not assume that it is simply part of the treatment. Speak to a healthcare professional so they can decide whether you need further assessment.

Can Weight Loss Injections Cause Dehydration?

The injection does not directly remove water from your body.

Dehydration can happen when side effects such as:

vomiting

or

diarrhoea

cause you to lose too much fluid.

The MHRA advises people using GLP 1 medicines to stay hydrated and warns that severe dehydration can sometimes lead to serious complications.

If vomiting or diarrhoea is severe or persistent, contact your healthcare professional.

Should You Drink More Water on Weight Loss Injections?

Staying adequately hydrated is important, particularly if you develop vomiting or diarrhoea.

The MHRA advises people using GLP 1 medicines to drink plenty of fluids to help prevent dehydration.

However, there is no need to force excessive amounts of water. If you have another medical condition that requires you to limit fluids, follow the advice given by your healthcare professional.

Do Weight Loss Injections Make You Eat Much Less?

They can reduce appetite and make some people feel fuller, which may lead to eating less.

However, the aim is not to eat as little as possible.

The MHRA advises people using GLP 1 medicines to maintain good nutrition and physical activity while using treatment.

If your appetite becomes so low that you are struggling to eat or drink enough, contact your prescribing service for advice.

Can You Lose Muscle While Losing Weight?

Weight loss can involve changes in more than body fat, including changes in lean tissue.

This is one reason nutrition and physical activity remain important during weight management treatment.

The MHRA advises people using GLP 1 medicines to maintain good nutrition and physical activity while taking treatment.

Your healthcare professional can help you work out what type and amount of activity is appropriate for your current health and ability.

Do You Still Need a Diet While Using Weight Loss Injections?

Yes.

Weight management medicines are intended to be used as part of a wider treatment plan. NICE recommends using medicines such as tirzepatide, semaglutide and liraglutide alongside a reduced calorie diet and increased physical activity.

The medicine can help with appetite and food intake, but it does not replace balanced nutrition or other parts of your weight management plan.

Do You Need to Exercise?

Physical activity is part of the wider weight management approach recommended by NICE.

That does not mean you need to exercise intensely or try to burn as many calories as possible.

Regular activity can support:

• physical function
• fitness
• muscle and overall physical health
• long term weight management.

Start with activity that matches your current ability and build up gradually if appropriate.

Can You Use Weight Loss Injections During Pregnancy?

Weight management medicines such as GLP 1 receptor agonists and tirzepatide are not intended for use during pregnancy.

NICE advises that tirzepatide, semaglutide and liraglutide should not be used during pregnancy. Specific contraception advice also applies to some of these medicines.

If you are planning a pregnancy, think you may be pregnant or become pregnant while using treatment, contact your prescribing healthcare professional for advice.

What If You Need an Operation?

Tell your surgical team and anaesthetist that you are taking a GLP 1 or related medicine before an operation or procedure.

These medicines can slow the emptying of the stomach. This can be important during general anaesthesia or deep sedation because stomach contents may enter the lungs.

Do not stop or change your medicine on your own because an operation is planned. Your surgical and prescribing teams can advise you on what to do.

Can Weight Loss Injections Be Used for Quick Cosmetic Weight Reduction?

Weight loss injections are prescription medicines authorised for specific medical uses. They should not be treated as quick cosmetic slimming products.

The MHRA has warned people against using GLP 1 medicines for quick weight loss outside their authorised indications and against buying them from illegal or unregulated sellers.

If your main goal is cosmetic weight reduction rather than treatment of overweight or obesity, speak to a healthcare professional about what options are appropriate for you.

Can You Use an Injection if Your BMI Is Below 27?

The authorised UK weight management indications for the medicines discussed here generally start at a BMI of 27 kg/m² when there is also a relevant weight related health condition, or at 30 kg/m² without that additional condition, depending on the medicine and its licence.

A BMI below 27 kg/m² therefore falls outside these usual weight management indications.

Do not try to obtain treatment from an unregulated source simply because you do not meet the criteria for a prescription. Products sold outside regulated healthcare channels may not contain what they claim to contain and may carry additional risks.

What If Your BMI Falls During Treatment?

Your treatment should be reviewed as your weight changes.

The aim is not uncontrolled weight loss, and becoming underweight may be a reason to review or stop certain medicines.

For example, NICE's current type 2 diabetes guidance says GLP 1 receptor agonists or tirzepatide should be stopped if a person becomes underweight, defined as a BMI below 18.5 kg/m². This recommendation relates specifically to treatment in adults with type 2 diabetes, so it should not be presented as a universal stopping rule for every person using a weight management medicine.

If your BMI changes significantly during treatment, speak to your prescriber about whether your current treatment remains appropriate.

Can You Change From One Injection to Another?

Sometimes, a prescriber may decide that changing to another medicine is appropriate.

However, do not switch between injections on your own.

Different medicines have different doses, schedules and prescribing instructions. Your prescriber needs to consider why you are changing, how you have responded to the current medicine and whether the new treatment is suitable.

Do not:

combine injections

use leftover doses

or

work out your own dose conversion.

If you are considering a change, discuss it with your prescriber.

Can You Take Two Weight Loss Injections at Once?

Do not combine prescription weight management injections unless a qualified prescriber has specifically told you to do so.

Different medicines can have similar effects on appetite and the digestive system, and combining treatments without medical advice could increase the risk of side effects.

More medicine does not automatically mean better or faster weight loss.

How Long Do You Stay on a Weight Loss Injection?

There is no single treatment length that applies to every weight loss injection or every person.

How long treatment continues can depend on:

• the medicine
• how well it is working
• side effects
• your ongoing eligibility
• the prescribing pathway
• your individual health needs.

NICE recommends semaglutide and liraglutide within specialist weight management services, which are usually accessed for up to 2 years. Tirzepatide has a different treatment framework, including a review after 6 months on the highest tolerated dose if less than 5% of initial body weight has been lost.

Treatment may continue for longer when appropriate, but this should be decided with your healthcare professional rather than based on a fixed timeline.

What If a Weight Loss Injection Does Not Work?

Not seeing the change you expected does not mean you should increase the dose yourself.

Weight loss can vary from person to person, so treatment should be reviewed with your prescriber rather than changed without medical advice.

For tirzepatide, NICE recommends reviewing whether treatment should continue if less than 5% of the initial body weight has been lost after 6 months on the highest tolerated dose.

For semaglutide, NICE recommends considering stopping treatment if less than 5% of the initial body weight has been lost after 6 months.

These are planned treatment review points, not a reason to increase the dose yourself.

Can Weight Return After Stopping Injections?

It can.

Weight management does not automatically stop when a medicine is discontinued. Changes in appetite and eating patterns may occur after stopping treatment, and some people may regain weight.

This is why longer term habits remain important, including:

dietary habits

physical activity

and

behavioural strategies.

NICE recommends ongoing support to help people maintain weight loss after stopping weight management medicines.

If you are thinking about stopping your medicine, speak to your prescriber first so that you can discuss what happens next.

Can Weight Loss Injections Cause Hair Shedding?

Some people notice hair shedding while losing a significant amount of weight. This can happen during periods of rapid weight reduction and is not necessarily evidence that the medicine has directly damaged the hair follicles.

It may be worth discussing with your healthcare professional if:

weight is coming off very quickly

you are eating very little

your diet has become limited

or

you are concerned that you are not getting enough nutrients.

There can also be other reasons for hair shedding, so persistent or noticeable hair loss should not automatically be blamed on the injection.

Are Weight Loss Injections Suitable for Everyone?

No. A weight loss injection that is suitable for one person may not be suitable for another.

This is why a proper prescribing assessment is important. Your suitability can depend on things such as:

• BMI
• existing health conditions
• current medicines
• pregnancy or plans for pregnancy
• previous side effects
• your individual treatment needs.

The fact that a particular medicine is popular does not mean it is the right choice for you.

What Should a Weight Loss Injection Consultation Include?

A proper consultation should give you a chance to discuss your health rather than simply selecting a product.

Depending on the service and medicine, the prescriber may review:

• height
• weight
• BMI
• weight history
• weight related health conditions
• current medicines
• allergies
• previous weight management treatment
• relevant medical history
• treatment expectations.

You should also be given information about:

• why a particular medicine has been considered
• how the dose is increased
• common side effects
• symptoms that need urgent medical attention
• how your treatment will be monitored
• when your treatment should be reviewed.

If you do not understand why a medicine has been prescribed or what to expect from it, ask the prescriber or pharmacist before starting treatment.

What Are Red Flags When Buying Weight Loss Injections?

Be cautious if a seller:

• offers prescription treatment without a proper clinical assessment
• sells through social media messages
• supplies powdered vials that need mixing before injection
• offers retatrutide for use in the UK
• encourages unusually high starting doses
• promises extreme or very rapid weight loss
• does not clearly identify the pharmacy supplying the medicine.

The MHRA has warned about illegal retatrutide products and unregulated GLP 1 medicines. It also advises people to obtain prescription weight management medicines through legitimate healthcare routes.

If an offer seems too easy, unusually cheap or makes unrealistic promises, take a moment to check who is actually supplying the medicine.

Weight Loss Injections UK: Key Takeaway

Thinking about a weight loss injection can bring up a lot of questions, especially when different BMI rules, medicines and treatment claims appear online.

Weight loss injections are prescription treatments that may help eligible adults manage overweight or obesity. They are not quick slimming products and are intended to be used alongside dietary changes and increased physical activity.

Current NICE adult weight management guidance includes three main injectable medicines:

tirzepatide

semaglutide

and

liraglutide.

The answer to “What BMI do I need for a weight loss injection?” depends on which criteria you are looking at.

For the broad UK authorised weight management indications of relevant GLP 1 medicines, treatment generally covers:

BMI of 30 kg/m² or above

or

BMI of 27 kg/m² or above with a relevant weight related health condition.

However, NICE criteria for NHS treatment can be narrower.

For example, NICE recommends tirzepatide for adults with an initial BMI of at least 35 kg/m² plus at least one weight related comorbidity, with lower BMI thresholds usually applied for certain ethnic backgrounds.

There is also a difference between a new medicine and a new presentation of an existing medicine.

Tirzepatide is the newer major active injectable medicine among the current NICE weight management injection options. In April 2026, the MHRA also approved a new single dose 7.2 mg Wegovy pen. This contains semaglutide, so it is a new pen and dose presentation rather than a completely new active medicine.

Retatrutide is different. It should not currently be described as an available UK weight management medicine. The MHRA warned in July 2026 that retatrutide had not been authorised for use in the UK and that products being sold as retatrutide were illegal.

Results should also be viewed realistically.

You may notice changes in appetite before you see a major change on the scales, but treatment response is assessed over months rather than after just a few injections. NICE uses specific review points for medicines such as semaglutide and tirzepatide, including assessing whether at least 5% of initial body weight has been lost after 6 months in the relevant circumstances.

You may also come across terms such as “weight loss injection face”. This is an informal phrase used online to describe facial slimming after substantial weight loss. It is not a separate medical diagnosis in current NICE or MHRA weight management guidance.

Kidney stones are another area where it is easy to get confused.

Current MHRA guidance does not identify kidney stones as a characteristic GLP 1 class side effect. However, vomiting and diarrhoea can cause dehydration, which can sometimes lead to serious kidney complications. Gallstones are different from kidney stones, and gallbladder problems are recognised in GLP 1 safety information.

Overall, weight loss injections can be one part of medical weight management for people who meet the relevant criteria. Whether treatment is appropriate depends on more than BMI alone. The medicine, health history, other medicines, treatment pathway and individual risks all need to be considered.

If you are prescribed an injection, follow the dosing schedule provided by your healthcare professional and have your treatment reviewed as recommended. Do not increase the dose, combine medicines, switch injections or use unauthorised products without appropriate medical advice.

Medical Disclaimer

This article provides general educational information about weight management injections in the UK. It does not determine whether a particular medicine is suitable for you, confirm individual eligibility or provide a prescription.

BMI is only one part of a weight management assessment, and NHS treatment criteria may differ from a medicine's broader authorised indication.

Prescription weight management medicines can cause side effects and may not be suitable for everyone. They should be obtained through legitimate regulated healthcare routes.

Do not increase doses, combine medicines, switch injections or use unauthorised injectable products without appropriate clinical advice.

Seek urgent medical attention if you develop severe and persistent abdominal pain, sudden loss of vision, severe vomiting or diarrhoea that prevents you from keeping fluids down, or another serious or unexpected symptom.